Dissolving microneedle patch-assisted transdermal delivery of methotrexate improve the therapeutic efficacy of rheumatoid arthritis

Methotrexate (MTX) is a first-line treatment for rheumatoid arthritis (RA), but its clinical use is greatly limited by the adverse effects and poor patient compliance caused by traditional oral administration or injection. In recent years, some transdermal drug delivery systems have received conside...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Weiman, Zheng, Lijie, Yang, Jianhui, Ma, Zihui, Tao, Xinyi, Wang, Qingqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769132/
https://www.ncbi.nlm.nih.gov/pubmed/36533887
http://dx.doi.org/10.1080/10717544.2022.2157518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769132/
https://www.ncbi.nlm.nih.gov/pubmed/36533887
http://dx.doi.org/10.1080/10717544.2022.2157518

Ejemplares similares